CHARLESTOWN PHARMACY LIMITED

🌳Matureactive
SC391110 · ltd · incorporated 2011-01-06
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
  • · Thesis: well-run, low negotiation leverage
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Jun 2025
Net worth
—
book net assets
Opportunity
81/100
Exceptional
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch
What this business does
Primary activity: General medical practice activities
Sector: Human health & social work
Investor take
Pursue
Active trading company with a 64-year-old founder — textbook succession opportunity.

Opportunity 81/100 (exceptional), bankability 75/100. Strong seller-intent signal (70/100, director aged 64). Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
6 officers (3 active, 6 linked, 4 with DOB)
83
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
1 connected companies via shared directors
48
Filing history
42 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
81/100Exceptional
PassWatchWorth a lookStrongExceptional 

Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
85
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
—
Net Worth
—
Current Assets
—
Current Liabilities
—
£0£0£0£0£0£0Jun 2024Jun 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2025-06-302024-06-30
Average employees5500

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • • 1 accounts
Last 180 days
2
filings
  • • 1 accounts
  • • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (25 events)Click to expand
  1. 2026-03-23
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2025-03-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  3. 2024-12-19
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  4. 2024-03-25
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  5. 2023-08-14
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  6. 2023-03-16
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  7. 2023-02-15
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  8. 2023-02-15
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC01
  9. 2022-03-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  10. 2021-03-19
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  11. 2020-03-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  12. 2019-04-01
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  13. 2018-04-05
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  14. 2017-03-28
    📄
    accounts-with-accounts-type-total-exemption-small
    accounts · AA
  15. 2016-03-21
    📄
    accounts-with-accounts-type-total-exemption-small
    accounts · AA
  16. 2011-01-06
    🏢
    Company incorporated
    As CHARLESTOWN PHARMACY LIMITED
  17. 2011-01-06
    ➕
    CHAN, Yuk, Dr appointed
    secretary
  18. 2011-01-06
    ➕
    CHAN, Yuk, Doctor appointed
    director
  19. 2011-01-06
    ➕
    FLEMING, Charles appointed
    director
  20. 2011-01-06
    ➕
    TRAINER, Peter appointed
    secretary
  21. 2011-01-06
    ➖
    TRAINER, Peter resigned
    secretary
  22. 2011-01-06
    ➕
    MCINTOSH, Susan appointed
    director
  23. 2011-01-06
    ➖
    MCINTOSH, Susan resigned
    director
  24. 2011-01-06
    ➕
    TRAINER, Peter appointed
    director
  25. 2011-01-06
    ➖
    TRAINER, Peter resigned
    director

Owner dependency

76/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Long-tenure founder: Senior director has been in place 15 years — deep operational knowledge concentrated in one person.
  • +Senior director age: Director aged approximately 64 — approaching natural succession window.

Succession & seller-readiness

79/100
Likely off-market candidate

Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
  • secondary12+ year tenure: Director in role 15 years.
  • secondaryStable-but-static management: Company is 15 years old and no new directors in the last 3 years — succession not yet being planned internally.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Mr Charles Fleming
Individual · British · DOB 10/1962 · age 64
25–50%
25–50%25-50% shares · 25-50% voting30/06/2016
Dr. Yuk Chan
Individual · Scottish · DOB 01/1966 · age 60
25–50%
25–50%25-50% shares · 25-50% voting30/06/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Healthcare & medical · KY postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
BAKOLINA LIMITED→
SC811315 · est 2024 · no financials extracted
————1y——
COMELY PARK DENTAL PRACTICE LTD.→
SC445337 · est 2013 · no financials extracted
————13y——
D ALLAN LIMITED→
SC244241 · est 2003 · no financials extracted
————23y——
DR CAMPBELL PSYCHOTHERAPY LTD→
SC848333 · est 2025 · no financials extracted
———————
FIFE SHOPPING & SUPPORT SERVICES LTD→
SC384248 · est 2010 · no financials extracted
————15y——
FIRST FOOT FIFE LTD→
SC648883 · est 2019 · no financials extracted
————6y——
FLOWERBURN MEDICAL LIMITED→
SC688830 · est 2021 · no financials extracted
————5y——
FOUR EYES RADIOLOGY LTD→
SC874472 · est 2026 · no financials extracted
———————
GGMT LIMITED→
SC376373 · est 2010 · no financials extracted
————16y——
HANDY SERVICES (FIFE) LTD→
SC567560 · est 2017 · no financials extracted
————8y——
HARMONYLITE LTD→
SC814226 · est 2024 · no financials extracted
————1y——
HEALTH MECHANIC LTD→
SC860245 · est 2025 · no financials extracted
———————
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2011-01-06
Jurisdictionscotland
Primary SIC86210 — General medical practice activities

Registered office

1a Main Road
Charlestown
Fife
KY11 3ED
United Kingdom

Filing status

Accounts
Next due: 2027-03-31
Last made up to: 2025-06-30
Confirmation statement
Next due: 2027-01-02
Last: 2025-12-19

Officers (3 active · 3 resigned)

CHAN, Yuk, Dr→
secretary · appointed 2011-01-06
View their other companies + combined net worth →
Active
CHAN, Yuk, Doctor→
director · ~60y · appointed 2011-01-06
View their other companies + combined net worth →
Active
FLEMING, Charles→
director · ~64y · appointed 2011-01-06
View their other companies + combined net worth →
Active
TRAINER, Peter→
secretary · appointed 2011-01-06 · resigned 2011-01-06
Resigned
MCINTOSH, Susan→
director · ~56y · appointed 2011-01-06 · resigned 2011-01-06
Resigned
TRAINER, Peter→
director · ~74y · appointed 2011-01-06 · resigned 2011-01-06
Resigned

Click a director name to see their full track record across all companies.

Recent filings (42 total)

accounts-with-accounts-type-total-exemption-full
accounts · AA
2026-03-23
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-12-22
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-03-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-12-19
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2024-12-19
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-03-25
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-12-19
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-08-14
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-03-16
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-02-15
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2023-02-15
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC01
2023-02-15
accounts-with-accounts-type-total-exemption-full
accounts · AA
2022-03-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-01-05
accounts-with-accounts-type-total-exemption-full
accounts · AA
2021-03-19